Transcript Revitalizing the Roll Back Malaria Case Management Working

REVITALIZING THE ROLL BACK MALARIA
CASE MANAGEMENT WORKING GROUP
Rationale

Although significant progress has been made in malaria
control, enormous challenges remain to scaling up timely
access to effective diagnosis and treatment for malaria.

Effective case management is a fundamental element of
successful malaria control, a key component of Global
Malaria Action Plan strategy and essential to achieving
the Millennium Development Goals.

New challenges in case management have created more
opportunities to make progress, provided that coherent
action among key stakeholders can be achieved.

A revitalized Case Management Working Group is urgently
needed to facilitate that coherent action.
Background

The Case Management Working Group operated successfully
for two years, from 2003 to 2004.

It played a key role in generating consensus around the push
for ACT adoption by countries as first-line treatment.

The RBM Partnership Board recognizes emerging challenges
in case management and has strongly endorsed the
revitalization of the working group to address these issues.
RBM Case Management Working Group
The Case Management Working Group creates a
valuable forum for technical experts to:

Discuss key issues in expanding access to effective treatment

Develop new strategies and methods for scaling up

Identify and document the best practices from field experience

Disseminate information and implementation updates

Identify key scale-up gaps, priorities for action, and if needed
organize task forces to address them
Areas requiring coherent and concerted action by
the Case Management Working Group
Progress to scale-up and a strong commitment to meet global
targets has created new challenges in case management, including:

Scaling up malaria diagnosis, including in the context of changing
transmission intensities

Preventing and managing the spread of artemisinin resistance

Access and delivery systems including quality of services and case reporting

Quality and safety of drugs and diagnostics
Objectives of the Meeting
 To review and revise TORs and composition (membership,
chairs and secretariat) for the Case Management Working
Group to submit to the next RBM Board Meeting
 To map the actors and activities on treatment access issues
globally
 To identify key bottlenecks and opportunities where
coordinated action is needed, including



Prevention and management of drug resistance, diagnostics, access
and quality
Identify priority areas for action and modalities including task forces
Develop one-year action plan and outline budget